- Joined
- Nov 21, 1998
- Messages
- 12,568
- Reaction score
- 6,966
Neuromodulation offers hope for patients with long-COVID
With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New York City, USA) outlines the potential neuromodulation holds regarding this unmet need. There is an urgent need to best understand...
neuronewsinternational.com
"Because COVID-19 is ubiquitous and will become endemic, PASC is especially troublesome in regard to cumulative disease burden. While vaccines and drugs are US Food and Drug Administration (FDA)-approved to moderate short-term symptoms, protection against PASC is unclear. The success of neuromodulation for PASC will depend on identifying device- and symptom-specific mechanisms. Given the unknowns about PASC itself, one method for doing this is to measure biomarkers of disease progression and response to treatment. Ultimately, home-based neuromodulation should be integrated with wearable health monitors and telemedicine, thereby supporting fully remote comprehensive treatment protocols."